Examining the Relationship Between Vitamin D and Progressive Multiple Sclerosis
Vitamin D deficiency is a risk factor for multiple sclerosis.
Vitamin D deficiency is a risk factor for multiple sclerosis.
Data obtained from the iConquerMS network highlight areas of quality of life that affect people with relapsing and progressive forms of MS and provide substantial basis for future research.
Patients with multiple sclerosis who were motivated to remain adherent to treatment experienced overall better outcomes, including low relapse rates.
Barriers to using screening tools included lack of time and lack of insurance compensation.
Poor medication timing, incorrect doses, medication disorganization, and under- or over-medication are some of the medication adherence issues that can occur in patients with MS and cognitive symptoms.
The association suggests that caffeine consumption may play a protective role against multiple sclerosis-related disability.
Intakes of fats and types of fatty acids may affect disability severity in multiple sclerosis and neuromyelitis optica spectrum disorder.
A significant unmet need remains for an effective, well-tolerated, and convenient treatment for patients with progressive forms of MS.
The EFFECT study compared the efficacy of dimethyl fumarate vs other disease-modifying therapies, including fingolimod and glatiramer acetate in patients with relapsing-remitting multiple sclerosis.
A 55-year-old woman with multiple sclerosis and no history of thyroid disease developed lab abnormalities suggestive of thyrotoxicosis on routine testing.